Consolidated Statement of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Operating activities:
Net loss	$ (988,126)	$ (1,928,128)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	142,935	50,540
Beneficial conversion feature on convertible notes payable	0	108,987
Amortization of convertible loan discoount	54,548	0
Fair value of common stock issued for services	113,930	135,459
Fair value of warrants issued to former officer	96,974	0
Fair value of warrants issued for shares of common stock	201,920	0
Fair value of options issued for services	113,233	221,511
Fair value of options issued to Directors, Employees and Consultants	234,865	0
Gain on change in fair value and extinguishment of derivatives liabilities, net	(21,420)	(19,007)
Allowance for inventory obsolescence	88,875	0
Patent write-down	0	21,758
Effect of changes in:
Inventory	(55,553)	(48,581)
Prepaid expenses and other current assets	(3,125)	(20,516)
Accounts payable and accrued expenses	(65,644)	129,242
Accrued payroll and payroll taxes	23,417	843,490
Related party payables, net	(34,608)	43,858
Advances from distributor	1,090,663	125,000
Advances from customers	(136,533)	100,000
Deferred revenue	(147,444)	130,494
Net cash provided by (used in) operating activities	708,907	(105,893)
Investing activities:
Purchase of property and equipment	(90,058)	(22,552)
Payments for patents	(30,487)	(31,022)
Net cash used in investing activities	(120,545)	(53,574)
Financing activities:
Proceeds from (payments on) bank loan borrowings	(349,276)	(136,834)
Proceeds from convertible notes payable	153,000	85,000
Payments on convertible notes payable	(86,550)	0
Proceeds from sales of common stock	0	35,000
Proceeds from related party short-term loans	0	84,250
Payment of related party short-term loans	(100,000)	0
Proceeds from short-term loans	0	214,521
Payments of short-term loans	(75,349)	0
Purchase of common stock	(25,460)	0
Net cash (used in) provided by financing activities	(483,635)	281,937
Net increase in cash	104,727	122,470
Cash, beginning of period	137,249	14,779
Cash, end of period	301,006	137,249
Supplemental disclosures of cash flow information:
Cash paid for interest	47,359	69,280
Cash paid for income taxes	0	1,600
Supplemental disclosure of non-cash investing and financing activities:
Fair value of warrants issued in connection with convertible note	90,106	0
Conversion of accounts payable and accrued expenses to short-term loan	20,349	0
Fair value of derivative liability recorded upon issuance of convertible note	15,149	0
Conversion of convertible notes payable and accrued interest to common stock	$ 25,460	$ 152,127